Effects of histocompatibility and host immune responses on the tumorigenicity of pluripotent stem cells
Tóm tắt
Tài liệu tham khảo
Brivanlou AH, Gage FH, Jaenisch R, Jessell T, Melton D, Rossant J (2003) Stem cells. Setting standards for human embryonic stem cells. Science 300:913–916
Lister R, Pelizzola M, Kida YS, Hawkins RD, Nery JR, Hon G, Antosiewicz-Bourget J, O'Malley R, Castanon R, Klugman S, Downes M, Yu R, Stewart R, Ren B, Thomson JA, Evans RM, Ecker JR (2011) Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471:68–73
Schuldiner M, Itskovitz-Eldor J, Benvenisty N (2003) Selective ablation of human embryonic stem cells expressing a "suicide" gene. Stem Cells 21:257–265
Cao F, Li Z, Lee A, Liu Z, Chen K, Wang H, Cai W, Chen X, Wu JC (2009) Noninvasive de novo imaging of human embryonic stem cell-derived teratoma formation. Cancer Res 69:2709–2713
Csete M (2010) Translational prospects for human induced pluripotent stem cells. Regen Med 5:509–519
Simpson E, Scott D, Chandler P (1997) The male-specific histocompatibility antigen, H-Y: a history of transplantation, immune response genes, sex determination and expression cloning. Annu Rev Immunol 15:39–61
Frenzel LP, Abdullah Z, Kriegeskorte AK, Dieterich R, Lange N, Busch DH, Krönke M, Utermöhlen O, Hescheler J, Saric T (2009) Role of NKG2D-ligands and ICAM-1 in NK cell-mediated lysis of murine embryonic stem cells and embryonic stem cell-derived cardiomyocytes. Stem Cells 27:307–316